Patent classifications
A61M1/3666
METHOD AND SYSTEM FOR CONTROLLED HYPERTHERMIA
Methods and for treatment of cancer and other diseases including complications from late stage viral infections by inducing hyperthermia in a patient relying on withdrawing blood from the patient and returning the withdrawn blood to the patient to establish an extracorporeal flow circuit. Blood is heated by passing through the extracorporeal circuit at a controlled rate until a target body core temperature in is achieved. Usually, the blood will be subjected to a continuously re-circulating dialysis to balance electrolytes. Additionally, the blood will be subjected to a continuously recirculating regeneration through a carbon sorbent column where toxins and contaminants are removed. The blood temperature is maintained at the target blood temperature for a treatment period, and the blood is cooled after the treatment period has been completed. The method can also be effective in treating rheumatoid arthritis, scleroderma, hepatitis, sepsis, the Epstein-Barr virus, and patients with life threatening complications from other viruses, including the COVID-19 virus. A method for removing viruses from the blood supply in an external circuit is also presented.
Method and system for controlled hyperthermia
Methods and for treatment of cancer and other diseases including complications from late stage viral infections by inducing hyperthermia in a patient relying on withdrawing blood from the patient and returning the withdrawn blood to the patient to establish an extracorporeal flow circuit. Blood is heated by passing through the extracorporeal circuit at a controlled rate until a target body core temperature in is achieved. Usually, the blood will be subjected to a continuously re-circulating dialysis to balance electrolytes. Additionally, the blood will be subjected to a continuously recirculating regeneration through a carbon sorbent column where toxins and contaminants are removed. The blood temperature is maintained at the target blood temperature for a treatment period, and the blood is cooled after the treatment period has been completed. The method can also be effective in treating rheumatoid arthritis, scleroderma, hepatitis, sepsis, the Epstein-Barr virus, and patients with life threatening complications from other viruses, including the COVID-19 virus. A method for removing viruses from the blood supply in an external circuit is also presented.
SENSOR SYSTEM AND MEDICAL DEVICE
A sensor system (10) has a medical device provided with a first transmission/reception unit (16) installed inside a medical instrument (12) to output a detection signal of a sensor unit (22), and a second transmission/reception unit (18) detachably installed outside the medical instrument (12) to transmit/receive a signal to and from the first transmission/reception unit (16) in a contactless manner. The first transmission/reception unit (16) and the second transmission/reception unit (18) are arranged so as to be opposed to each other across the medical instrument (12) to transmit/receive the signal by electromagnetic induction.
Venting system with a venting unit and a venting device set and method of operating a venting system
A deaerating device set allows a priming circuit to be deaerated fully automatically using a deaerating unit and a priming control unit, a priming liquid container and preferably a priming pump or a priming compressor. A blood pump is operated in a pulsatile manner during the pumping of a priming fluid.
IMPROVED OXYGENATOR FOR USE WITH EXTRACORPOREAL SUPPORT OF PREMATURE FETUS
Disclosed are devices and methods directed to oxygenators for use in extracorporeal circuits for supporting a fetus. An oxygenator for use with an extracorporeal circuit includes a housing defining a cavity therein and a gas exchanger disposed within the interior cavity. The cavity is configured to receive blood a fetus. The gas exchanger is configured to receive a sweep gas and further configured to contact the blood within the cavity, such that at least oxygen gas and carbon dioxide gas is permitted to diffuse between the blood and the gas exchanger.
Bidirectional flow catheter
Disclosed herein is a bidirectional intravascular cannula, or catheter, that is configured to provide and return blood in a patient bidirectionally. The bidirectional intravascular cannula is configured to reduce or obviate the need for a second cannula, such as currently available unidirectional cannulae, to be placed in a second or opposite direction of flow. Users would include cardiac surgeons, intensivists, vascular surgeons, ER doctors, IR doctors and cardiologist who use peripheral cannulation for ECLS or cardiopulmonary bypass. The cannula allows continued flow to a patient's limb even with the cannula proximally in the vessel. The cannula further allows larger size cannula to be placed without the need for additional distal catheter placement.
SYSTEMS AND METHODS FOR REMOVING GASEOUS MICRO EMBOLI FROM BLOOD
A system for removing gaseous micro emboli from blood prior to oxygenation. The system including a module having a blood inlet, a blood outlet, and a port configured to provide atmospheric or sub-atmospheric pressures, and microporous hollow fibers situated in the module and fluidly coupled to the port to provide the atmospheric or sub-atmospheric pressures inside the microporous hollow fibers. The module is configured to receive the blood through the blood inlet such that the blood flows from the blood inlet to the blood outlet around outside surfaces of the microporous hollow fibers such that at least some of the gaseous micro emboli in the blood are drawn from the blood through the microporous hollow fibers by the atmospheric or sub-atmospheric pressures.
GAS DELIVERY SYSTEM
A gas delivery system is provided. The gas delivery system includes a pump operable to receive blood from a patient. A gas transfer unit is in fluid communication with the pump and operable to receive the blood from the pump and deliver a therapeutic amount of xenon gas to the blood. A patient connector withdraws and/or infuses the blood into the patient.
DUAL LUMEN DRAINAGE CANNULA WITH SINGLE OUTLET
A dual lumen drainage cannula configured for use in a veno-arterial extracorporeal membrane oxygenation (VA ECMO) system includes a first drainage tube having a proximal end, a distal end, and at least one aperture defined in the distal end. The dual lumen drainage cannula further includes a second drainage tube having a proximal end, a distal end, and at least one aperture defined in the distal end. The dual lumen drainage cannula further includes an outlet fitting in fluid communication with the first drainage tube and the second drainage tube. The distal end of the second drainage tube is joined to a portion of the first drainage tube between the proximal and distal ends of the first drainage tube.
Hybrid venous reservoir
The invention is an innovative hybrid venous reservoir designed to receive and store blood during cardiopulmonary bypass (CPB), the hybrid venous reservoir consisting of an air purging chamber that limits air in the venous blood entering the air purging chamber from exiting the air purging chamber in combination with a compliant storage chamber with at least one pliable wall, the combination providing a large volume capacity while limiting the area of the blood-air interface to that of the air purging chamber.